Бендамустин Сандоз (Bendamustine Hydrochloride)

Бендамустин Сандоз is a chemotherapy medication used to treat certain types of cancer. It belongs to the class of alkylating agents and is administered intravenously. This product is manufactured by Sandoz Pharmaceuticals D.D. and is available in the EU market.

Бендамустин Сандоз is primarily used to treat chronic lymphocytic leukemia and non-Hodgkin lymphoma. It may also be prescribed for other types of cancer as determined by a healthcare professional. This medication works by interfering with the growth of cancer cells. Patients often ask, 'what is bendamustine hydrochloride used for' in clinical settings.

Common effects of Бендамустин Сандоз include nausea, fatigue, and lowered blood cell counts. Some patients may experience hair loss or increased susceptibility to infections. These effects vary depending on individual health conditions and treatment duration. Always consult a healthcare provider for personalized advice.

Бендамустин Сандоз should be handled with care, especially by healthcare professionals administering the drug. It may cause harm if it comes into contact with skin or mucous membranes. Pregnant or breastfeeding individuals should avoid exposure. Proper disposal methods must be followed to prevent environmental contamination.

This medication may interact with other drugs, including CYP1A2 inhibitors or live vaccines. Alcohol and certain herbal supplements could also affect its efficacy or increase side effects. Patients should inform their healthcare provider about all medications and supplements they are taking. Avoiding alcohol during treatment is often recommended.